tag:blogger.com,1999:blog-8550428.post5369942787071730140..comments2024-03-27T01:34:23.434-04:00Comments on Pharma Marketing Blog: Big Sunshine Law DataVladhttp://www.blogger.com/profile/04114063498108633047noreply@blogger.comBlogger3125tag:blogger.com,1999:blog-8550428.post-37630404667576339052013-05-17T13:43:12.735-04:002013-05-17T13:43:12.735-04:00John, i'd be happy to share what I know. let&#...John, i'd be happy to share what I know. let's connect on linkedin.Paul Golotahttps://www.blogger.com/profile/15775043044488744296noreply@blogger.comtag:blogger.com,1999:blog-8550428.post-1605206080389567142013-03-14T12:46:59.558-04:002013-03-14T12:46:59.558-04:00Paul,
Thanks for that detail. I'll have to re...Paul,<br /><br />Thanks for that detail. I'll have to read the regs more carefully myself. Maybe I can pick your brain about this and other tidbits pharma should know about the inclusions/exclusions.PharmaGuyhttps://www.blogger.com/profile/10211557578124130640noreply@blogger.comtag:blogger.com,1999:blog-8550428.post-22045590878466242902013-03-14T12:39:09.349-04:002013-03-14T12:39:09.349-04:00At least there is a reporting exclusion for double...At least there is a reporting exclusion for double-blinded market research studies. Hopefully pharma will be educated on this exclusion, so as not to unnecessarily require reporting from MR companies.Paul Golotahttps://www.blogger.com/profile/15775043044488744296noreply@blogger.com